Literature DB >> 27408377

Primary Intraocular Diffuse Large B-cell Lymphoma: Diagnostic Difficulties in Deep Retinal Infiltrations with Vitritis.

Katarzyna Kapelko-Slowik1, Donata Urbaniak-Kujda2, Anna Turno-Krecicka3, Stanislaw Potoczek1, Jaroslaw Dybko1, Monika Biernat4, Miroslaw Slowik3.   

Abstract

PURPOSE: Primary intraocular lymphoma (PIOL) is a rare malignancy with an aggressive clinical course. It is usually considered as a subset of primary central nervous system lymphoma. Differential diagnosis should include infectious and non-infectious aetiologies, particularly the common masqueraders sarcoidosis, tuberculosis, viral retinitis and syphilis. PATIENT: The article presents a case of bilateral vitreoretinal lymphoma manifesting as uveitis and vitritis resistant to corticosteroid therapy. The final diagnosis was based on a retinal biopsy.
RESULTS: The patient was successfully treated with systemic and local therapy. Long-term complete remission (CR) was reached. The relapse of diffuse large B-cell lymphoma was revealed in the frontal left lobe after 48 months of CR duration.
CONCLUSION: The diagnosis of PIOL is always very difficult. Cooperation of pathologists, ophthalmologists and hematologists is required for a quick and accurate diagnosis. Local and systemic treatment is needed to achieve CR, but the relapse rate remains very high.

Entities:  

Keywords:  Chemotherapy; Lymphoma; Retinal infiltration; Uveitis; Vitritis

Year:  2015        PMID: 27408377      PMCID: PMC4925530          DOI: 10.1007/s12288-015-0599-x

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  7 in total

Review 1.  Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium.

Authors:  Chi-Chao Chan; James L Rubenstein; Sarah E Coupland; Janet L Davis; J William Harbour; Patrick B Johnston; Nathalie Cassoux; Valerie Touitou; Justine R Smith; Tracy T Batchelor; Jose S Pulido
Journal:  Oncologist       Date:  2011-11-01

Review 2.  Rituximab for intraocular lymphoma.

Authors:  Sujit Itty; Jose S Pulido
Journal:  Retina       Date:  2009-02       Impact factor: 4.256

3.  Treatment of primary intraocular lymphoma (PIOL) has involved systemic, intravitreal or intrathecal chemotherapy and/or radiotherapy.

Authors:  Sujit Itty; Joshua H Olson; Dennis J O'Connell; Jose S Pulido
Journal:  Retina       Date:  2009-03       Impact factor: 4.256

Review 4.  Primary intraocular lymphoma.

Authors:  Mandeep S Sagoo; Hemal Mehta; Andrew J Swampillai; Victoria M L Cohen; Sepideh Z Amin; P Nicholas Plowman; Sue Lightman
Journal:  Surv Ophthalmol       Date:  2013-12-31       Impact factor: 6.048

5.  Primary uveal lymphoma with epibulbar extension masquerading as an intraocular inflammation.

Authors:  Denis Jusufbegovic; Vivian Kim; Devron H Char
Journal:  Can J Ophthalmol       Date:  2015-02       Impact factor: 1.882

6.  Primary intraocular lymphoma.

Authors:  Lisa J Faia; Chi-Chao Chan
Journal:  Arch Pathol Lab Med       Date:  2009-08       Impact factor: 5.534

7.  Evaluation of vitrectomy specimens and chorioretinal biopsies in the diagnosis of primary intraocular lymphoma in patients with Masquerade syndrome.

Authors:  Sarah E Coupland; Nikolaos E Bechrakis; Gerasimos Anastassiou; Andreas M H Foerster; Arnd Heiligenhaus; Uwe Pleyer; Michael Hummel; Harald Stein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-09-30       Impact factor: 3.117

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.